HHS and EPA Launch Coordinated Federal Push on Microplastics in U.S. Water and Bodies
Health and Human Services Secretary Robert F. Kennedy Jr. and EPA Administrator Lee Zeldin announced a new federal drive to confront microplastics, formally adding microplastics and pharmaceuticals to EPA’s Contaminant Candidate List for drinking water for the first time and launching HHS’s Systematic Targeting of Microplastics (STOMP) research initiative. The Contaminant Candidate List move is a key procedural step that elevates microplastics as priority pollutants for monitoring, funding and possible future regulation, though any binding drinking‑water standards would still require further rulemaking and likely congressional involvement. STOMP will focus on how different types of microplastics accumulate in organs such as the heart and brain and how they may drive inflammation, oxidative stress, endocrine disruption and associated risks like heart attack, stroke, fertility problems and neurodegenerative disease. Kennedy framed the effort as forcing industry to "clean up after" itself instead of shifting costs to the public, while NYU physician‑researcher Leonardo Trasande compared the current moment to early lead‑exposure regulation, arguing that emerging science justifies action even before every mechanism is fully mapped. The initiative reflects growing public concern and social‑media debate about plastics in food, water and air, and positions the Trump administration’s HHS and EPA as moving—at least on this issue—toward tighter scrutiny of chemical and pharmaceutical pollution in the U.S. environment.
📌 Key Facts
- EPA is adding microplastics and pharmaceuticals to its official Contaminant Candidate List for drinking water for the first time, a step that helps prioritize monitoring, funding and potential future regulation.
- HHS is launching a new national research effort called the Systematic Targeting of Microplastics (STOMP) to study how various microplastics accumulate in the human body and affect health.
- HHS Secretary Robert F. Kennedy Jr. and EPA Administrator Lee Zeldin unveiled the initiative on April 2, 2026, in an announcement and interview in Washington, D.C., citing emerging evidence that some microplastics act as endocrine disruptors and may increase risks of cardiovascular and neurodegenerative disease.
- NYU professor Dr. Leonardo Trasande likened the microplastics response to the early U.S. crackdown on lead exposure in the 1970s, urging precautionary action based on current evidence rather than waiting for perfect certainty.
- Kennedy criticized major corporations for contributing to pervasive plastic and pharmaceutical contamination and said they, rather than the public, should bear primary responsibility and costs for cleanup and mitigation.
📊 Relevant Data
In California, Black individuals consumed 36.1% more bottled water per capita than Whites, leading to 30-77% higher daily microplastic exposure across income levels, while Hispanics consumed 13.2% more than non-Hispanics, resulting in 8-34% higher exposure.
Microplastic exposure disparities in California communities through bottled water consumption — Microplastics and Nanoplastics (Springer)
Non-Hispanic Black adults in the US have a total cardiovascular disease prevalence of 63.0% for males and 59.5% for females, compared to 52.8% for Non-Hispanic White males and 43.5% for females, with age-adjusted CVD mortality rates of 598.6 per 100,000 for Blacks versus 253.4 per 100,000 for Whites.
2026 Stats Update Fact Sheet US Sex Race Ethnicity and CVD — American Heart Association
Black Medicare beneficiaries in North and South Carolina had a 4% higher risk of all-cause hospitalization for neurodegenerative diseases compared to White beneficiaries, were 38% less likely to receive physical/occupational therapy, and spent 14% fewer days in hospice facilities.
Racial/ethnic disparities in dementia incidence, outcomes, and health‐care utilization — Alzheimer's & Dementia (Wiley)
Black and Hispanic women in the US experience lower pregnancy and live birth rates from fertility treatments compared to White women, with disparities persisting despite use of preimplantation genetic testing.
U.S. Racial and Ethnic Disparities in Outcomes Using Preimplantation Genetic Testing for Aneuploidy — PubMed (NCBI)
📰 Source Timeline (1)
Follow how coverage of this story developed over time